We constructed a LASSO prognostic model containing five genes, including NOP2, NSUN2, TET1, YBX1, and DNMT3B (Figures 2D,E), and a median risk score was used to separate HCC patients into two groups. This evidence concerns the gene DNMT3B and hepatocellular carcinoma.